Please login to the form below

Not currently logged in
Email:
Password:

Chugai appoints Ruth Currie as MD of its UK business

She replaces John Halls, who has been promoted

Ruth Currie, Chugai UKChugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business.

Currie takes over from John Halls, who also receives a promotion that sees him become managing director for Chugai's commercial activities across Europe.

In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche since 2002. She will also join Chugai's European leadership team.

Currie has been with Chugai, the original developers of RoAcemtra, since 2009, holding several senior positions, including most recently as UK sales director.

11th February 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics